Modern SFE: Purpose-Driven Performance, Proven Returns

Modern SFE: Purpose-Driven Performance, Proven Returns

• 1.
  SALESFORCE ON A WHEELCHAIR? Timefor a power-packed recovery plan.
• 2.
  DISEASE MANAGEMENT DEMANDSPRECISION, NOT PRESSURE. CLINICAL SYMPTOMS Product Knowledge Skills Gap Attitude GAP Understanding PK/PD reveals how a drug moves and acts, MoA clarifies its biological pathway, and RCT interpretation validates safety and efficacy— empowering confident, science-driven clinical decisions. Strong communication, psychological understanding, and influence through ethical commitments enhance engagement—driving better treatment acceptance and meaningful behaviour change. Cognitive trust activation, emotional resonance, behavioral influence, and identity- driven care ensure patients feel valued— creating confident and lasting healing relationships.
• 3.
  FROM PUSH TOPRECISION STARATEGIC PROTOCOL Product Knowledge TRADITIONAL TRAINING CHALLENGES SFE TRAINING ADVANTAGES Push Weak Science Monologue No Change One Size Short Lived Disease First Credibility Influence Behaviour Personalize Sustain
• 4.
  HUMAN TOUCH, CLINICAL STRENGTH WHAT IS SFE?DNA OF SFE? SFE + KSA INTEGRATION? HOW SFE EMPOWERS TEAMS FOR BETTER ROI ? Sales Force Effectiveness ensures every customer interaction delivers scientific value, behavioural influence, and measurable outcomes — transforming sales from product push to purpose- driven performance. Right Customer Right Message Right Moment Knowledge →Strong disease & therapy impact Skills →Confident communication & behaviour influence Attitude →Ethical, patient-centric conviction Together, they convert clinical conversations into meaningful adoption. SFE builds capability, accountability, and confidence — driving: ✔Higher HCP engagement ✔Better treatment acceptance ✔Stronger brand equity ✔Faster, sustainable growth More influence →More adoption →More ROI
• 5.
  SFE FRAMEWORK & ADVANTAGES Shift customer perception frompush to value. Strengths Market Trust & Relationship Capital Improve Financial Performance & ROI Generation Create Behavioural influence at the point of decisions Improve market predictability Enhance Competitive Differentiation Impact on Organization outcome Grater Operational Clarity across all level Higher productivity & Field Efficiency Faster & more accurate decision making Stronger Team Behaviour, culture & Alignment Transformation into a learning organization SFE TRASFORMATION
• 6.
  HOW SFE CHANGESDIFFERENT SELLING MODELS? B2B STRATEGIC HEALTHCARE PARTNERSHIPS D2C PHARMA & BIOTECH CONSUMER WELLNESS & ADHERENCE (CONCEPTUAL / SCIENCE-LED SELLING) TRADITIONAL TRADITIONAL TRADITIONAL PRICE TALKS, TRANSACTIONAL SELLING PROMOTIONS AND DISCOUNTS PRODUCT PUSH & FEATURES SFE SFE SFE VALUE-DRIVEN, SOLUTION-BASED COLLABORATION WITH INSTITUTIONS AND NETWORKS EDUCATED, TRUSTED ENGAGEMENT DIRECTLY WITH PATIENTS/CONSUMERS DISEASE-FIRST CONVERSATIONS BACKED BY CLINICAL CREDIBILITY ✔ECONOMIC + CLINICAL EVIDENCE →LONG-TERM CONTRACTS ✔ HIGHER MARKET ACCESS & SHARE-OF-WALLET ✔CLEAR GUIDANCE → CONFIDENT HEALTH CHOICES ✔BEHAVIOUR SUPPORT → SUSTAINED USAGE ✔DIFFERENTIATION VIA PK/PD, MOA & RCT EVIDENCE ✔ADOPTION BASED ON PATIENT OUTCOME IMPACT 👉SHIFTS FROM VENDORS → HEALTHCARE PARTNERS 👉SHIFTS FROM BUYERS →BELIEVERS 👉SHIFTS FROM PRESCRIPTIONS → ADVOCACY
• 7.
  CASE STUDY GLOBAL PHARMA(CHRONIC THERAPY) CHALLENGE? Strong portfolio but stagnant growth High field activity with low HCP conversion Weak scientific communication & inconsistent messaging SFE INTERVENTIONS 1.Disease-first engagement model 2.PK/PD + MoA–based scientific readiness 3.Segmented HCP targeting & precise messaging 4.“Right Message–Right Moment” call strategy 5.Continuous capability coaching via dashboards SEE REFERENCE IMPACT (12 MONTHS) 1.18–22% ↑in Rx depth of top brands 2.37% ↑adoption in high-value HCP segment 3.28% ↓in unproductive calls 4.20% ↑ROI through improved influence
• 8.
  CASE STUDY BIOTECH (SPECIALITYIMMUNOLOGY) CHALLENGE? Complex MoA leading to low HCP conviction Inconsistent scientific narrative in field teams Slow prescriber onboarding SFE INTERVENTIONS 1.Advanced scientific capability (MoA + RWE + RCT interpretation) 2.Influence-based clinical conversation frameworks 3.KSA integration: Knowledge + Skills + Attitude 4.Multichannel specialist engagement 5.Behavioural KPIs replacing activity KPIs SEE REFERENCE IMPACT (9 MONTHS) 1.42% ↑in treatment initiations 2.30% faster prescriber onboarding 3.HCP satisfaction improved 3.2 →4.5 4.25% ↑ROI through stronger scientific credibility
• 9.
  1.SHAPING THE NEXTERA OF PHARMA 2.EMPOWER. INFLUENCE. IMPROVE OUTCOMES. KEY TAKEAWAY CH Co HC In na Slo SFE = CAPABILITY × CREDIBILITY × CONSISTENCY HOW SFE DRIVES ROI? 1.PREPARED TEAMS →CONFIDENT SCIENTIFIC CONVERSATIONS 2.PRECISE ENGAGEMENT →TARGETED INFLUENCE 3.PROVEN BEHAVIOURAL IMPACT → FASTER ADOPTION 4.ELIMINATES WASTE, STRENGTHENS OUTCOMES, INCREASES REVENUE CONNECT US +91 9828134199 INQUIRE NOW DOWNLOAD CURRICULUM